Dpt. Chairman of the Supervisory Board

Dr. Axel Müller, born in 1957, has been, since the identity-preserving change of legal form from Mutares AG to Mutares SE & Co. KGaA on 24 July 2019, a member of the Supervisory Board of Mutares SE & Co. KGaA and Deputy Chairman of this body; until this change of legal form he has been a member of the Supervisory Board of Mutares AG since 2018 and it’s Deputy Chairman since 8 April 2019. Since January 2019 he is the Chairman of the Audit Committee of the Supervisory Board of Mutares SE & Co. KGaA and since July 2019 he is also a member of the Supervisory Board of Mutares Management SE.

From 1985 to 2010, Dr. Axel Müller held numerous management positions at STADA Arzneimittel AG in the areas of Marketing and Communication, Strategy and M&A as well as Operations; most recently as a member of the Executive Board since 2010, he was responsible for Production and Development. Dr. Axel Müller has been an independent management consultant since 2014. After several years as Senior Advisor at Arthur D. Little, he became Associate Partner at Fidelio Healthcare Partners in 2018.

Dr. Axel Müller is a licensed pharmacist; after completing his pharmaceutical studies at the Johannes-Gutenberg University in Mainz in 1980, he worked there for several years as a research assistant and received his doctorate in pharmaceutical technology.